Fusco v. New York Racing & Wagering Board

88 A.D.3d 1240, 931 N.Y.2d 439
CourtAppellate Division of the Supreme Court of the State of New York
DecidedOctober 27, 2011
StatusPublished
Cited by6 cases

This text of 88 A.D.3d 1240 (Fusco v. New York Racing & Wagering Board) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fusco v. New York Racing & Wagering Board, 88 A.D.3d 1240, 931 N.Y.2d 439 (N.Y. Ct. App. 2011).

Opinion

Lahtinen, J.

[1241]*1241Petitioner was the trainer of the horse Chevie Pride, and a post-race test of the horse following its win at Yonkers Raceway in December 2006 was positive for the drug Clenbuterol, which is not to be administered within 96 hours of a race. The presiding track judge assessed a fine of $2,500 and suspended petitioner’s license to participate in pari-mutuel harness racing for 18 months in October 2007. He pursued an administrative appeal and, at the commencement of the hearing, respondent sought to amend the charges to include additional violations of administering the drugs Robaxin and Naquasone to the horse within 72 hours of races on five separate occasions in late 2006. The amendment was permitted, but the hearing was adjourned until November 2008.

Proof at the subsequent hearing included, among other things, testimony of respondent’s investigator and its expert as well as various documents. However, petitioner’s objection to respondent’s offer of the horse’s veterinary records from November 2006 and December 2006 was sustained by the Hearing Officer and, without those records, the Hearing Officer, while recommending upholding the violation and penalty regarding Clenbuterol, further recommended dismissal of the additional charges related to Robaxin and Naquasone. On review, respondent determined that the veterinary records should have been admitted into evidence, and thus remanded the matter to the Hearing Officer to admit those records and receive additional proof with respect thereto. The Hearing Officer admitted the records, but received no other evidence. As a result of the failure to develop the record as previously ordered, respondent directed a further hearing unless the parties stipulated to the nature and pharmacological properties of the pertinent drugs.

The parties did not stipulate and the original Hearing Officer had retired; accordingly, a further hearing was conducted before a new hearing officer in November 2009. The Hearing Officer determined that petitioner had improperly administered Robaxin and Naquasone on five occasions and recommended that, in addition to the penalty for the original violation related to the use of Clenbuterol, petitioner’s license be revoked for five years. Respondent adopted the Hearing Officer’s report and imposed the recommended penalty. Petitioner then commenced this CPLR article 78 proceeding, which Supreme Court transferred to this Court (see CPLR 7804 [g]).

Petitioner argues that substantial evidence does not support respondent’s determination that he violated the rules prohibiting administering Robaxin and Naquasone within 72 hours of a [1242]*1242race since the amounts of such drugs in the horse did not rise to the level of a positive test.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Matter of Pena v. New York State Gaming Commission
144 A.D.3d 1244 (Appellate Division of the Supreme Court of New York, 2016)
Beckwith v. Sabini
105 A.D.3d 1185 (Appellate Division of the Supreme Court of New York, 2013)
Dutrow v. New York State Racing & Wagering Board
97 A.D.3d 1034 (Appellate Division of the Supreme Court of New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
88 A.D.3d 1240, 931 N.Y.2d 439, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fusco-v-new-york-racing-wagering-board-nyappdiv-2011.